p-Hydroxybenzoate esters metabolism in MCF7 breast cancer cells

被引:29
|
作者
Dagher, Zeina [2 ]
Borgie, Mireille [2 ]
Magdalou, Jacques [3 ]
Chahine, Ramez [2 ]
Greige-Gerges, Helene [1 ,2 ]
机构
[1] Lebanese Univ, Fac Sci, Doctoral Sch Sci & Technol, Bioact Mol Res Grp,Sect 2, Jdaidet El Matn, Lebanon
[2] Lebanese Univ, Fac Sci 2, Dept Chem & Biochem, Jdaidet El Matn, Lebanon
[3] Univ Henri Poincare, UMR CNRS 7561, Nancy 1, France
关键词
MCF7; cells; homogenates; Parabens; Cytotoxicity; Metabolism; BODY TOPICAL APPLICATION; HUMAN LIVER; HUMAN CARBOXYLESTERASE; SUBSTRATE-SPECIFICITY; ESTROGENIC ACTIVITY; GENE-EXPRESSION; PARABENS; HYDROLYSIS; EXPOSURE; HUMANS;
D O I
10.1016/j.fct.2012.08.013
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Parabens are among the most frequently used preservatives to inhibit microbial growth and extend the shelf life of a range of consumer products. The objective of the present study was to gain insight into the metabolism of parabens in breast cancer cells (MCF7) since they have demonstrated estrogenic activity towards these cells and have been detected in breast cancer tissues. The toxicity of parabens to MCF7 cells was determined using MTT assays. Hydrolysis of methyl-, butyl and benzyl-paraben to p-hydroxybenzoic acid was analyzed in cultured MCF7 cells and in cellular homogenates. Glucuronidation and sulfoconjugation were studied in MCF7 homogenates, and parabens were analyzed by HPLC. Methyl-paraben was shown to be far less toxic than butyl and benzyl-paraben. Parabens were completely stable in MCF7 homogenates whereas p-nitrophenyl acetate, a substrate type, underwent hydrolysis. MCF7 cell homogenates did not express glucuronidation and sulfoconjugation activities toward parabens. The higher stability of parabens may explain their accumulation in breast cancer tissue as previously reported in the literature. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4109 / 4114
页数:6
相关论文
共 50 条
  • [21] Effect of survivin siRNA on biological behaviour of breast cancer MCF7 cells
    Wang, Hao
    Ye, Yi-Feng
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2015, 8 (03) : 225 - 228
  • [22] Progesterone sensitizes breast cancer MCF7 cells to imatinib inhibitory effects
    Rocha, Ana
    Azevedo, Isabel
    Soares, Raquel
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 103 (02) : 607 - 614
  • [23] Transesterification of p-hydroxybenzoate esters (parabens) by human intestinal (Caco-2) cells
    Lakeram, M.
    Paine, A. J.
    Lockley, D. J.
    Sanders, D. J.
    Pendlington, R.
    Forbes, B.
    [J]. XENOBIOTICA, 2006, 36 (09) : 739 - 749
  • [24] A New Assay to Distinguish Between the Breast Cancer MCF7 and MCF7/ ADR-resistant Cells Based on Exosomal RNA.
    Abdelaziz, Mohammed H.
    Abdelnaser, Anwar
    El Sawy, Ehab N.
    [J]. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2023, 59 : S97 - S97
  • [25] Estrogen receptor alpha transcriptionally regulates p53 in MCF7 human breast cancer cells
    Berger, Crystal
    Qian, Yingjuan
    Chen, Xinbin
    [J]. CANCER RESEARCH, 2012, 72
  • [26] Christia vespertilionis extract induced antiproliferation and apoptosis in breast cancer (MCF7) cells
    Ismail, Noor Zafirah
    Adebayo, Ismail Abiola
    Mohamed, Wan Ahmad Syazani
    Mohamad Zain, Nur Nadhirah
    Arsad, Hasni
    [J]. MOLECULAR BIOLOGY REPORTS, 2021, 48 (11) : 7361 - 7370
  • [27] Mdm2 sensitizes MCF7 breast cancer cells to cisplatin or carboplatin
    Smith, ML
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1999, 58 (02) : 99 - 105
  • [28] Transcription Regulation Network Analysis of MCF7 Breast Cancer Cells Exposed to Estradiol
    Wu, Jun-Zhao
    Lu, Peng
    Liu, Rong
    Yang, Tie-Jian
    [J]. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3681 - 3685
  • [29] A meta-analysis assessing the cytotoxicity of nanoparticles on MCF7 breast cancer cells
    Konuk, Elcin Yenidunya
    [J]. ONCOLOGY LETTERS, 2024, 28 (05)
  • [30] SYNTHESIS OF ARTEMISININ DIMERS AND THEIR BIOLOGICAL EVALUATION AGAINST MCF7 BREAST CANCER CELLS
    Tsoukala, P.
    Magoulas, G. E.
    Antoniou, A.
    Athanassopoulos, C. M.
    Papaioannou, D.
    Papadimitriou, E.
    Tsigkou, T.
    Lamprou, M.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 : E226 - E226